• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthbees

How Maryland Lawmakers Are Trying to Save Bees

By
John Kell
John Kell
Contributing Writer and author of CIO Intelligence
Down Arrow Button Icon
By
John Kell
John Kell
Contributing Writer and author of CIO Intelligence
Down Arrow Button Icon
March 25, 2016, 1:14 PM ET
518638797
Bees and honeycombsKerstin Klaassen—Getty Images

Legislation that is being crafted in Maryland could make the state the first in the nation to ban the sale of certain insecticides in an effort to save the declining honey bee population.

Separate bills have cleared the Maryland State Senate and Maryland House of Delegates and because they are similar enough, they are expected to be combined into a single piece of legislation for Republican Gov. Larry Hogan’s consideration to sign into law, the Portland Press Herald reported.

The bill would specifically ban neonicotinoids, which are a class of pesticides that are a purported major contributing factor to population declines for bees. Honey bees are an important component in U.S. agriculture, as about a third of our diet is directly or indirectly tied to that species.

But insecticides are one cause that some say has attributed to declining hives and honey production. The Department of Agriculture reported that honey production tumbled 12% in 2015, with honey-harvesting colonies dropping 3%. Maryland lost more than 60% of its hives last year, said the Portland Press Herald.

Other states are considering similar action. And on the federal level, Representatives John Conyers, Jr. (D-Mich.) and Earl Blumenauer (D-OR) last year reintroduced the Saving America’s Pollinators Act of 2015, which would require the suspension of some insecticides until the Environmental Protection Agency can review if they are harmful to bees and other pollinators.

“The EPA plans to wait until 2018 before reviewing the registration of neonicotinoids. But America’s bees cannot wait three more years,” said Conyers in a statement when he talked up that act. That bill still hasn’t won approval in either the Senate nor the House of Representatives.

About the Author
By John KellContributing Writer and author of CIO Intelligence

John Kell is a contributing writer for Fortune and author of Fortune’s CIO Intelligence newsletter.

See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Most Popular

placeholder alt text
Future of Work
Ford CEO has 5,000 open mechanic jobs with up to 6-figure salaries from the shortage of manually skilled workers: 'We are in trouble in our country'
By Marco Quiroz-GutierrezJanuary 31, 2026
1 day ago
placeholder alt text
Economy
'I just don't have a good feeling about this': Top economist Claudia Sahm says the economy quietly shifted and everyone's now looking at the wrong alarm
By Eleanor PringleJanuary 31, 2026
2 days ago
placeholder alt text
Success
Ryan Serhant starts work at 4:30 a.m.—he says most people don’t achieve their dreams because ‘what they really want is just to be lazy’
By Preston ForeJanuary 31, 2026
1 day ago
placeholder alt text
Big Tech
The Chan Zuckerberg Initiative cut 70 jobs as the Meta CEO’s philanthropy goes all in on mission to 'cure or prevent all disease'
By Sydney LakeFebruary 1, 2026
14 hours ago
placeholder alt text
Success
U.S. Olympic gold medalist went from $200,000-a-year sponsorship at 20 years old to $12-an-hour internship by 30
By Orianna Rosa RoyleFebruary 1, 2026
9 hours ago
placeholder alt text
Economy
Meet the first CEO of the IRS: A Jamie Dimon protégé facing a $5 trillion test this tax season
By Shawn TullyJanuary 31, 2026
2 days ago

Latest in Health

Several pictures of people receiving medical treatments including a facelift and oxygen therapy.
HealthSuper Bowl
Hims and Hers Super Bowl ad highlights ‘uncomfortable truth’ about elite healthcare for the rich and ‘broken’ system for the rest
By Jacqueline MunisFebruary 1, 2026
15 hours ago
Healthsleep
9 Best Mattresses for Couples in 2026: Tested and Reviewed
By Christina SnyderJanuary 30, 2026
2 days ago
Healthoutdoor and sporting goods
5 Best Sauna Blankets of 2026: Tested by Recovery Experts
By Christina SnyderJanuary 30, 2026
2 days ago
A person laying on a bed in a store.
Healthmattresses
How to Choose a Mattress: The Ultimate Guide
By Jessica RendallJanuary 30, 2026
2 days ago
HealthScience
As billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial
By Marco Quiroz-GutierrezJanuary 30, 2026
3 days ago
C-SuiteFortune 500: Titans and Disruptors of Industry
Pfizer CEO says he used ‘emotional blackmail’ to get employees to achieve impossible goals during COVID-19
By Eva RoytburgJanuary 29, 2026
3 days ago